AndroGel Cost in Iowa 2026: Cash Price, Insurance, Medicaid, and Compounding Options

What Is the Cash Price for AndroGel in Iowa?

The retail cash price for AndroGel in Iowa is approximately $510 per month for either the 1% or 1.62% formulation in 2026. That figure reflects AbbVie's manufacturer list price, which has remained in that range across most U.S. retail chains. Prices at independent Iowa pharmacies, Hy-Vee Pharmacy, CVS, and Walgreens are broadly consistent with that number for a 30-day supply without insurance or a coupon.

Brand-name AndroGel contains testosterone as the active ingredient and is FDA-approved for hypogonadism in adult males. The FDA approval label for AndroGel 1.62% is accessible on AbbVie's NDA record at the FDA. The FDA label specifies starting doses of 40.5 mg (two pump actuations) once daily for the 1.62% gel, with titration based on serum testosterone drawn 14 days after initiation or after any dose change.

Price variation between pharmacies in Iowa is generally small for a brand-name product with a protected patent, rarely more than $15 to $30 per month. Discount aggregators such as GoodRx or RxSaver may list coupons that bring the price toward $420 to $470, though coupon pricing can differ by zip code. The most current pricing for any individual zip code should be confirmed directly with the dispensing pharmacy.

The clinical rationale for testosterone replacement in confirmed hypogonadism is backed by the Testosterone Trials (T-Trials), a coordinated set of seven placebo-controlled trials (N=788 men aged 65 or older with serum testosterone <275 ng/dL) that demonstrated statistically significant improvements in sexual function, bone density, and anemia with testosterone treatment over 12 months [1]. Establishing medical necessity through a trial like the T-Trials data is exactly the kind of documentation insurers in Iowa ask for when you submit a prior authorization request.

Does Iowa Medicaid Cover AndroGel?

Iowa Medicaid does not cover AndroGel or other brand-name testosterone gels for male hypogonadism as a standard benefit in 2026. The Iowa Medicaid Preferred Drug List (PDL), administered by Iowa Total Care, Molina Healthcare of Iowa, and AmeriHealth Caritas Iowa under the managed care structure, excludes branded testosterone gel from routine outpatient pharmacy coverage for this indication. Generic testosterone gel (testosterone 1.62% gel, authorized generics from Perrigo or Teva) may carry different coverage status, but brand AndroGel is not a preferred product.

Iowa Medicaid does cover testosterone for specific diagnoses outside of adult male hypogonadism, including gender-affirming hormone therapy in some cases, depending on managed care organization policy and prior authorization. Patients seeking coverage under those pathways should work with their prescribing clinician to submit appropriate ICD-10 coding and supporting laboratory results.

The Iowa Medicaid preferred drug list updates are published by the Iowa Department of Health and Human Services and should be reviewed directly for the most current formulary status, as PDLs are revised quarterly.

For Medicaid beneficiaries who cannot afford brand AndroGel, clinicians may consider a medical exception request. Those requests require documented failure of or contraindication to covered alternatives. Approval rates for exception requests for testosterone gel under Iowa Medicaid are not publicly reported, and anecdotally these requests face significant scrutiny.

The Endocrine Society's 2018 clinical practice guideline on male hypogonadism recommends testosterone therapy "when there is unequivocal biochemical evidence of testosterone deficiency" (defined as two morning total testosterone measurements <300 ng/dL using a reliable assay) and when symptoms are present [2]. That guideline language is commonly cited in prior authorization letters and exception requests to document clinical necessity.

Which Commercial Insurance Plans Cover AndroGel in Iowa?

Most commercial insurance plans sold in Iowa cover some form of testosterone replacement therapy, but brand AndroGel faces prior authorization requirements at nearly every carrier. The major commercial payers active in Iowa's individual and employer markets include Wellmark Blue Cross Blue Shield of Iowa, UnitedHealthcare, Aetna, and Medica. Each uses a different formulary tier and step-therapy protocol.

Wellmark BCBS of Iowa, the dominant carrier by market share in the state, typically places brand AndroGel on Tier 3 or Tier 4, meaning patient cost-sharing after prior authorization approval can range from $80 to $200 per month depending on the specific plan design. Generic testosterone gel, where covered, appears on Tier 2 at lower cost-sharing. Wellmark's drug formulary tool allows members to check specific plan tier placement.

Step therapy is the primary barrier. Most Iowa commercial plans require a trial of generic testosterone gel or testosterone cypionate injection before they will approve AndroGel. The American Association of Clinical Endocrinology (AACE) position on testosterone formulation choice notes that transdermal gel produces more stable serum testosterone levels than biweekly injections in some patients, which can support a step-therapy override when documented [3].

Prior authorization approval generally requires: a diagnosis code of hypogonadism (ICD-10 E29.1 or similar), two morning serum testosterone results <300 ng/dL (or per carrier threshold), documentation of signs or symptoms, and prescriber attestation. Some plans also require a pituitary MRI or luteinizing hormone/FSH result to rule out secondary hypogonadism before approving long-term therapy.

How Does the AbbVie AndroGel Savings Card Work for Iowa Patients?

AbbVie offers a co-pay savings card for AndroGel that can reduce monthly cost to as low as $0 for eligible patients with commercial insurance. The program is called the myAbbVie Assist co-pay card, and it applies to patients who are commercially insured (not Medicaid, Medicare Part D, or any federal or state government program). Iowa patients who are privately insured and meet AbbVie's eligibility criteria can enroll online at the AbbVie manufacturer website.

The mechanics: the savings card acts as secondary coverage and covers the patient's out-of-pocket portion after insurance pays its share. The maximum annual benefit is capped (AbbVie has set this at $3,600 per calendar year historically, though the precise cap for 2026 should be confirmed on enrollment). Once that cap is reached, the patient pays standard cost-sharing for the remainder of the year.

For uninsured Iowa patients, AbbVie's myAbbVie Assist patient assistance program provides AndroGel at no cost to patients who meet income eligibility thresholds. The general threshold has historically been at or below 400% of the federal poverty level, but program terms change annually. The FDA's page on patient assistance programs links out to manufacturer assistance resources and is a useful starting point.

The savings card does not work for Iowa Medicaid or Medicaid managed care beneficiaries. Federal anti-kickback rules prohibit manufacturer co-pay assistance from applying to any government-payer plan.

Is Compounded Testosterone Gel Legal in Iowa, and What Does It Cost?

Compounded testosterone gel is legal in Iowa when prepared by a state-licensed 503A compounding pharmacy. Section 503A of the Federal Food, Drug, and Cosmetic Act permits traditional compounding pharmacies to prepare individualized medications based on a valid patient-specific prescription from a licensed prescriber. Iowa's Board of Pharmacy licenses and inspects 503A compounding pharmacies operating within the state, and the Iowa Board of Pharmacy maintains a public list of licensed compounders.

The practical cost difference is substantial. Where brand AndroGel runs $510 per month, a compounded testosterone gel from a licensed Iowa 503A pharmacy typically costs $100 to $120 per month. That price reflects compounding fees, the raw active pharmaceutical ingredient (testosterone USP), and the gel base (usually hydroalcoholic or PLO gel). The formulation is not FDA-approved as a finished product, but the active ingredient is identical.

Compounded testosterone gel is available in concentrations that differ from the commercial product. Common prescriptions include testosterone 10%, 20%, or custom concentrations in gram-measured syringes or pump dispensers. The Endocrine Society guideline notes that compounded preparations carry "potential risks of inaccurate dosing or sterility issues" and recommends FDA-approved formulations when available and financially feasible [2]. That caveat should be part of any shared decision-making conversation with your prescriber.

The FDA's guidance on compounding describes the 503A framework, including the requirement that prescriptions be patient-specific and not anticipatory (i.e., the pharmacy cannot stock large batches). Iowa patients receiving compounded testosterone gel via telehealth prescribers must have a valid patient-prescriber relationship established before the prescription is transmitted.

A 2020 systematic review published in the Journal of Clinical Endocrinology and Metabolism evaluated testosterone delivery across formulations, finding that transdermal testosterone (both branded and compounded preparations) achieved target serum levels (400 to 700 ng/dL) in approximately 60 to 70% of patients when dosed correctly, with skin-transfer risk as the primary safety concern for both forms [4].

Can Iowa Patients Get AndroGel via Telehealth?

Telehealth prescribing of AndroGel is legal in Iowa. Iowa follows federal DEA rules on Schedule III controlled substances: a valid prescription for testosterone can be issued via synchronous audio-video telehealth after the prescriber has established a patient-provider relationship that satisfies Iowa's standard of care. Since the COVID-era DEA telemedicine flexibilities began their phased wind-down in 2024, the DEA has proposed rules that would allow ongoing audio-video prescribing of Schedule III substances (including testosterone) without a prior in-person visit, though patients should confirm the current regulatory status with their telehealth provider.

Iowa Code 135.172 governs telehealth practice in the state and does not impose restrictions beyond federal controlled-substance rules for testosterone prescribing specifically. A licensed Iowa physician, physician assistant, or advanced registered nurse practitioner (ARNP) can evaluate symptoms, order serum testosterone and LH/FSH labs, and issue a prescription for AndroGel or compounded testosterone gel entirely through telehealth.

HealthRX operates licensed telehealth prescribers in Iowa. The clinical evaluation follows the T-Trials diagnostic threshold: two morning total testosterone measurements <275 to 300 ng/dL, confirmed symptoms consistent with hypogonadism, and exclusion of reversible causes before initiating therapy [1]. Lab results can be obtained at any LabCorp or Quest Diagnostics draw site in Iowa, with most standard testosterone panels (total testosterone, free testosterone, LH, FSH, CBC, PSA) running $75 to $150 cash-pay.

The HealthRX Iowa TRT Intake Framework requires three steps before a prescription is issued: (1) documented serum testosterone on two separate morning draws at a certified Iowa lab, (2) a structured symptom questionnaire scored against the Aging Males' Symptoms (AMS) scale, and (3) a synchronous video consultation with an Iowa-licensed prescriber reviewing labs, symptoms, contraindications (prostate cancer, hematocrit >54%, severe untreated sleep apnea, uncontrolled heart failure), and formulation preference. This framework aligns with the Endocrine Society 2018 guideline recommendation for individualized assessment before initiating testosterone therapy [2].

What Are the Real Costs Side by Side?

Breaking down the monthly cost for an Iowa patient starting testosterone gel therapy in 2026:

Brand AndroGel (cash, no coupon): approximately $510/month.

Brand AndroGel (with AbbVie co-pay card, commercially insured): as low as $0 to $30/month depending on plan tier and annual cap.

Brand AndroGel (commercial insurance, Tier 3, no savings card): $80 to $200/month after prior authorization.

Generic testosterone gel (commercial insurance, Tier 2): $30 to $80/month after prior authorization.

Compounded testosterone gel (503A Iowa pharmacy, cash): $100 to $120/month.

Iowa Medicaid (brand AndroGel): not covered.

The FDA's MedWatch program tracks adverse events for both brand and compounded testosterone products. Skin-transfer to female partners and children is the most commonly reported safety event for all topical testosterone formulations, and the FDA black box warning on AndroGel's label specifically addresses this risk.

A 2021 JAMA Internal Medicine analysis of testosterone prescribing patterns across the United States found that 19.3% of men who initiated testosterone therapy had not had a baseline testosterone level measured, highlighting the gap between guideline-recommended practice and real-world prescribing [5]. Iowa patients should confirm their prescriber has documented two morning testosterone measurements before starting any formulation.

Monitoring Costs After Starting AndroGel in Iowa

Starting AndroGel is not a one-time expense. Follow-up monitoring adds to the monthly budget. The Endocrine Society guideline recommends checking serum testosterone 14 days after dose initiation (to confirm absorption) and then at 3 months, 6 months, and annually once stable [2]. Each testosterone panel costs $40 to $90 at Iowa cash-pay labs.

Hematocrit must be checked at baseline, at 3 to 6 months, and annually, because testosterone stimulates erythropoiesis. A hematocrit above 54% is a threshold for dose reduction or temporary cessation under the current guideline [2]. PSA should be measured at baseline and at 3 to 12 months in men over 40, per the same guideline.

The American Urological Association's guideline on testosterone deficiency (2018, amended 2022) adds that digital rectal examination is recommended at baseline and at 12 months for men starting testosterone therapy [6]. DRE adds a modest office-visit cost if not bundled with the prescribing consultation.

Total first-year monitoring cost for an Iowa patient on testosterone gel, including the initial two testosterone draws, three to four follow-up panels, hematocrit checks, and one PSA panel, runs approximately $400 to $700 cash-pay if not covered by insurance.

Why Serum Testosterone Levels Matter Before You Buy

No Iowa pharmacy will dispense AndroGel or a compounded equivalent without a valid prescription, and no legitimate prescriber will write that prescription without documented low testosterone. The T-Trials defined hypogonadism for their enrollment criteria as two morning total testosterone measurements <275 ng/dL, drawn at a certified laboratory between 7 a.m. and 10 a.m. [1]. The Endocrine Society uses <300 ng/dL as the biochemical threshold, with symptoms required regardless of the number [2].

Men who purchase testosterone gel online from unlicensed sources bypass this screening. That pathway carries both legal risk (testosterone is a Schedule III controlled substance under 21 U.S.C. 812) and clinical risk: supraphysiologic testosterone suppresses endogenous production, reduces sperm count, and raises hematocrit. The FDA's controlled substance scheduling page provides background on testosterone's regulatory classification.

If your total testosterone is repeatedly above 300 ng/dL but you still have fatigue, low libido, or mood changes, the differential is broad: thyroid dysfunction, obstructive sleep apnea, depression, low-normal free testosterone (due to elevated SHBG), or other causes. A free testosterone level, measured by equilibrium dialysis rather than calculated, adds diagnostic precision. The AACE clinical practice guidelines for hypogonadism recommend free testosterone testing when total testosterone is equivocal [3].

How to Get the Lowest Price on AndroGel in Iowa: A Step-by-Step Approach

First, confirm the diagnosis with two morning testosterone draws. Second, check your commercial insurance formulary for testosterone gel tier placement and step-therapy requirements. Third, if you are commercially insured and AndroGel is prescribed, enroll in the AbbVie myAbbVie Assist co-pay card before filling the prescription. Fourth, if you are uninsured or if the brand price remains above your budget after the savings card, ask your HealthRX prescriber about a 503A compounded testosterone gel prescription from an Iowa-licensed compounding pharmacy, which brings the monthly cost to approximately $120. Fifth, if you are on Iowa Medicaid, ask your prescriber to file a pharmacy exception request citing the Endocrine Society guideline [2] and your documented lab values; approval is not guaranteed but the request is worth submitting.

Generic testosterone gel (Perrigo's authorized generic, for example) is chemically identical to AndroGel 1.62% and is available at some Iowa retailers for $180 to $280 cash-pay, splitting the difference between brand and compounded options [7].

The NIH's MedlinePlus page on testosterone provides patient-facing information on all approved testosterone formulations, including gel, injection, patch, and pellet, which may be useful when discussing alternatives with your prescriber.

Target serum testosterone on AndroGel therapy is 400 to 700 ng/dL for most adult men, drawn as a trough (the morning before the day's application), per the Endocrine Society guideline [2]. If your trough is consistently above 700 ng/dL, your prescriber should reduce the dose before any downstream cardiovascular or hematologic complications develop.